Clinical Trial

CMTS0929 for Clostridioides Difficile Infection

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This is a prospective, open-label, single-arm study to explore the safety and the efficacy of CMTS0929 for patients with Clostridioides difficile infection (CDI).
Trial Details
NCT Number NCT06836427
Lead Sponsor The Second Hospital of Nanjing Medical University
Conditions Clostridioides Difficile Infection
Enrollment 12 participants
Start Date 2025-02-20
Primary Completion 2030-01-31 (estimated)
Study Completion 2030-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-20